ResearcherNanjing Drum Tower HospitalActive in the last 2 years

Zhang Yin

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0009-0001-6120-6980; OpenAlex author ID A5101561056. Sources: OpenAlex.

Their work

Papers: 1
Trials: 0
Grants: 0
Labs led: 0
Collaborators: 5

Papers, trials and grants by year

2024: 1 paper

Papers 1

CAFs Homologous Biomimetic Liposome Bearing BET Inhibitor and Pirfenidone Synergistically Promoting Antitumor Efficacy in Pancreatic Ductal Adenocarcinoma. Co-author DOI 10.1002/advs.202305279 ↗

Closest collaborators

The 5 strongest of 5 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Shijin Xu · 1 shared paper, 2024 · strength 0.18
- Paper CAFs Homologous Biomimetic Liposome Bearing BET Inhibitor and Pirfenidone Synergistically Promoting Antitumor Efficacy … DOI 10.1002/advs.202305279 ↗
Ying Lv · 1 shared paper, 2024 · strength 0.18
- Paper CAFs Homologous Biomimetic Liposome Bearing BET Inhibitor and Pirfenidone Synergistically Promoting Antitumor Efficacy … DOI 10.1002/advs.202305279 ↗
Yixuan Zhang · 1 shared paper, 2024 · strength 0.18
- Paper CAFs Homologous Biomimetic Liposome Bearing BET Inhibitor and Pirfenidone Synergistically Promoting Antitumor Efficacy … DOI 10.1002/advs.202305279 ↗
Shu Zhang · 1 shared paper, 2024 · strength 0.18
- Paper CAFs Homologous Biomimetic Liposome Bearing BET Inhibitor and Pirfenidone Synergistically Promoting Antitumor Efficacy … DOI 10.1002/advs.202305279 ↗
Xiaoping Zou · 1 shared paper, 2024 · strength 0.18
- Paper CAFs Homologous Biomimetic Liposome Bearing BET Inhibitor and Pirfenidone Synergistically Promoting Antitumor Efficacy … DOI 10.1002/advs.202305279 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.